Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume -, Issue -, Pages -
Publisher
The Endocrine Society
Online
2022-10-01
DOI
10.1210/clinem/dgac549
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonist
- (2022) Ashley H. Shoemaker et al. INTERNATIONAL JOURNAL OF OBESITY
- MRI measures of hypothalamic injury are associated with GLP ‐1 receptor agonist treatment response in people with hypothalamic obesity
- (2021) Francisco A. Perez et al. DIABETES OBESITY & METABOLISM
- Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists
- (2021) Jamy Ard et al. ADVANCES IN THERAPY
- Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome
- (2021) Nathalie Kayadjanian et al. PLoS One
- A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
- (2020) Aaron S. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 3 randomized clinical trial using a o nce‐weekly glucagon‐like peptide‐1 receptor agonist in adolescents and young adults with hypothalamic obesity
- (2020) Christian L. Roth et al. DIABETES OBESITY & METABOLISM
- Assessment and management of hypoglycemia in children and adolescents with diabetes
- (2018) Mary B Abraham et al. PEDIATRIC DIABETES
- Obesity management in Prader–Willi syndrome: current perspectives
- (2018) Antonino Crinò et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
- (2017) Carel W le Roux et al. LANCET
- Prader–Willi syndrome: From genetics to behaviour, with special focus on appetite treatments
- (2015) Joanne L. Griggs et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoglycemia in Prader-Willi syndrome
- (2014) Rena A. Harrington et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Use of GLP-1 Receptor Agonists in Prader-Willi Syndrome: Report of Six Cases
- (2014) Danilo Fintini et al. DIABETES CARE
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases
- (2013) Flavius Zoicas et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of a Single Dose of Exenatide on Appetite, Gut Hormones, and Glucose Homeostasis in Adults with Prader-Willi Syndrome
- (2011) Lisa Sze et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Health Supervision for Children With Prader-Willi Syndrome
- (2010) PEDIATRICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search